Alan D. Tice

5.4k total citations
92 papers, 3.0k citations indexed

About

Alan D. Tice is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Alan D. Tice has authored 92 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 28 papers in Infectious Diseases and 24 papers in Epidemiology. Recurrent topics in Alan D. Tice's work include Antibiotics Pharmacokinetics and Efficacy (30 papers), Antimicrobial Resistance in Staphylococcus (21 papers) and Antibiotic Use and Resistance (16 papers). Alan D. Tice is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (30 papers), Antimicrobial Resistance in Staphylococcus (21 papers) and Antibiotic Use and Resistance (16 papers). Alan D. Tice collaborates with scholars based in United States, Italy and Canada. Alan D. Tice's co-authors include Susan J. Rehm, David N. Williams, John S. Bradley, J. R. Dalovisio, Donald R. Graham, Lawrence Martinelli, David Shoultz, Robert W. Yancey, M Künkel and R. Brooks Gainer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Alan D. Tice

85 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alan D. Tice 1.1k 995 917 651 579 92 3.0k
E. Patchen Dellinger 716 0.7× 1.1k 1.1× 1.5k 1.6× 1.7k 2.7× 570 1.0× 59 5.4k
Mary Andrus 446 0.4× 2.2k 2.2× 887 1.0× 1.4k 2.2× 729 1.3× 8 5.7k
David N. Williams 641 0.6× 2.1k 2.1× 540 0.6× 2.1k 3.2× 320 0.6× 62 3.6k
Chatrchai Watanakunakorn 645 0.6× 1.7k 1.7× 1.8k 1.9× 462 0.7× 649 1.1× 117 4.3k
R.A. Seaton 1.1k 1.1× 1.2k 1.2× 1.0k 1.1× 451 0.7× 1.1k 1.8× 119 3.0k
Konstantinos Z. Vardakas 1.8k 1.7× 2.6k 2.6× 1.7k 1.9× 405 0.6× 1.1k 1.9× 96 6.2k
Ronald Lee Nichols 494 0.5× 665 0.7× 828 0.9× 2.8k 4.3× 172 0.3× 142 4.8k
Christopher J. Crnich 211 0.2× 1.2k 1.2× 495 0.5× 359 0.6× 540 0.9× 102 3.5k
J. E. McGowan 383 0.4× 1.5k 1.5× 1.3k 1.4× 715 1.1× 803 1.4× 66 4.1k
Majdi N. Al‐Hasan 379 0.4× 1.2k 1.2× 375 0.4× 164 0.3× 865 1.5× 109 2.6k

Countries citing papers authored by Alan D. Tice

Since Specialization
Citations

This map shows the geographic impact of Alan D. Tice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Tice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Tice more than expected).

Fields of papers citing papers by Alan D. Tice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Tice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Tice. The network helps show where Alan D. Tice may publish in the future.

Co-authorship network of co-authors of Alan D. Tice

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Tice. A scholar is included among the top collaborators of Alan D. Tice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Tice. Alan D. Tice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rehm, Susan J. & Alan D. Tice. (2010). Staphylococcus aureus:Methicillin‐SusceptibleS. aureusto Methicillin‐ResistantS. aureusand Vancomycin‐ResistantS. aureus. Clinical Infectious Diseases. 51(S2). S176–S182. 66 indexed citations
2.
Brown, Joel D., et al.. (2007). Thyrotoxic periodic paralysis in a Polynesian male following highly active antiretroviral therapy for HIV infection.. PubMed. 66(3). 60, 62–3. 12 indexed citations
3.
Tice, Alan D., et al.. (2007). Culturally sensitive strategies designed to target the silent epidemic of hepatitis B in a Filipino community.. PubMed. 66(6). 154–6. 8 indexed citations
4.
Lipsky, Benjamin A., Peter Sheehan, David G. Armstrong, et al.. (2007). Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. International Wound Journal. 4(1). 30–38. 56 indexed citations
5.
Taira, Deborah A., et al.. (2005). A health plan intervention to improve pneumococcal vaccination in the elderly.. PubMed. 18(9). 25–30. 1 indexed citations
6.
Dalovisio, J. R., et al.. (2005). Evaluation of the Efficacy and Safety of Outpatient Parenteral Antimicrobial Therapy for Infections With Methicillin-sensitive Staphylococcus aureus. Southern Medical Journal. 98(6). 590–595. 43 indexed citations
7.
Lipsky, Benjamin A., David G. Armstrong, Diane M. Citron, et al.. (2005). Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. The Lancet. 366(9498). 1695–1703. 193 indexed citations
8.
Esposito, Silvano, Silvana Noviello, Sara Leone, et al.. (2004). Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. International Journal of Antimicrobial Agents. 24(5). 473–478. 87 indexed citations
9.
Tice, Alan D.. (2004). Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. Journal of Antimicrobial Chemotherapy. 53(suppl_2). ii83–ii86. 33 indexed citations
10.
Tice, Alan D., et al.. (2003). Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. The American Journal of Medicine. 114(9). 723–728. 143 indexed citations
11.
Esposito, Silvano, Silvana Noviello, Sebastiano Leone, et al.. (2002). [Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry].. PubMed. 10(3). 169–75. 6 indexed citations
12.
DeMaio, James, et al.. (2001). The Application of Telemedicine Technology to a Directly Observed Therapy Program for Tuberculosis: A Pilot Project. Clinical Infectious Diseases. 33(12). 2082–2084. 69 indexed citations
13.
Tice, Alan D.. (2000). Pharmacoeconomic Considerations in the Ambulatory Use of Parenteral Cephalosporins. Drugs. 59(Supplement 3). 29–35. 29 indexed citations
15.
Tice, Alan D.. (2000). Introduction. Chemotherapy. 47(Suppl. 1). 1–4. 7 indexed citations
16.
Tice, Alan D., et al.. (1999). Outpatient Parenteral Antimicrobial Therapy for Central Nervous System Infections. Clinical Infectious Diseases. 29(6). 1394–1399. 38 indexed citations
17.
Tice, Alan D., et al.. (1998). Medicare Coverage of Outpatient Ambulatory Intravenous Antibiotic Therapy: A Program that Pays for Itself. Clinical Infectious Diseases. 27(6). 1415–1421. 15 indexed citations
18.
Sexton, Daniel J., Marvin J. Tenenbaum, Walter R. Wilson, et al.. (1998). Ceftriaxone Once Daily for Four Weeks Compared with Ceftriaxone Plus Gentamicin Once Daily for Two Weeks for Treatment of Endocarditis Due to Penicillin-Susceptible Streptococci. Clinical Infectious Diseases. 27(6). 1470–1474. 123 indexed citations
19.
Williams, David N., Susan J. Rehm, Alan D. Tice, et al.. (1997). Practice Guidelines for Community‐Based Parenteral Anti‐Infective Therapy. Clinical Infectious Diseases. 25(4). 787–801. 93 indexed citations
20.
Tice, Alan D.. (1991). An Office Model of Outpatient Parenteral Antibiotic Therapy. Clinical Infectious Diseases. 13(Supplement_2). S184–S188. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026